Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 60

1.

Quantitative Neuroimaging Software for Clinical Assessment of Hippocampal Volumes on MR Imaging.

Ahdidan J, Raji CA, DeYoe EA, Mathis J, Noe KØ, Rimestad J, Kjeldsen TK, Mosegaard J, Becker JT, Lopez O.

J Alzheimers Dis. 2015 Oct 15;49(3):723-32. doi: 10.3233/JAD-150559.

PMID:
26484924
2.

The fornix in mild cognitive impairment and Alzheimer's disease.

Nowrangi MA, Rosenberg PB.

Front Aging Neurosci. 2015 Jan 21;7:1. doi: 10.3389/fnagi.2015.00001. eCollection 2015. Review.

3.

Detection of volume loss in hippocampal layers in Alzheimer's disease using 7 T MRI: a feasibility study.

Boutet C, Chupin M, Lehéricy S, Marrakchi-Kacem L, Epelbaum S, Poupon C, Wiggins C, Vignaud A, Hasboun D, Defontaines B, Hanon O, Dubois B, Sarazin M, Hertz-Pannier L, Colliot O.

Neuroimage Clin. 2014 Jul 31;5:341-8. doi: 10.1016/j.nicl.2014.07.011. eCollection 2014.

4.

A pilot study evaluating presurgery neuroanatomical biomarkers for postoperative cognitive decline after total knee arthroplasty in older adults.

Price CC, Tanner JJ, Schmalfuss I, Garvan CW, Gearen P, Dickey D, Heilman K, McDonagh DL, Libon DJ, Leonard C, Bowers D, Monk TG.

Anesthesiology. 2014 Mar;120(3):601-13. doi: 10.1097/ALN.0000000000000080.

5.

Gross feature recognition of Anatomical Images based on Atlas grid (GAIA): Incorporating the local discrepancy between an atlas and a target image to capture the features of anatomic brain MRI.

Qin YY, Hsu JT, Yoshida S, Faria AV, Oishi K, Unschuld PG, Redgrave GW, Ying SH, Ross CA, van Zijl PC, Hillis AE, Albert MS, Lyketsos CG, Miller MI, Mori S, Oishi K.

Neuroimage Clin. 2013 Aug 14;3:202-11. doi: 10.1016/j.nicl.2013.08.006. eCollection 2013.

6.

Shared vulnerability of two synaptically-connected medial temporal lobe areas to age and cognitive decline: a seven tesla magnetic resonance imaging study.

Kerchner GA, Bernstein JD, Fenesy MC, Deutsch GK, Saranathan M, Zeineh MM, Rutt BK.

J Neurosci. 2013 Oct 16;33(42):16666-72. doi: 10.1523/JNEUROSCI.1915-13.2013.

7.

Estradiol prevents olfactory dysfunction induced by A-β 25-35 injection in hippocampus.

Bernal-Mondragón C, Rivas-Arancibia S, Kendrick KM, Guevara-Guzmán R.

BMC Neurosci. 2013 Sep 24;14:104. doi: 10.1186/1471-2202-14-104.

8.

MRI markers for mild cognitive impairment: comparisons between white matter integrity and gray matter volume measurements.

Zhang Y, Schuff N, Camacho M, Chao LL, Fletcher TP, Yaffe K, Woolley SC, Madison C, Rosen HJ, Miller BL, Weiner MW.

PLoS One. 2013 Jun 6;8(6):e66367. doi: 10.1371/journal.pone.0066367. Print 2013.

9.
10.

Dissociating memory networks in early Alzheimer's disease and frontotemporal lobar degeneration - a combined study of hypometabolism and atrophy.

Frisch S, Dukart J, Vogt B, Horstmann A, Becker G, Villringer A, Barthel H, Sabri O, Müller K, Schroeter ML.

PLoS One. 2013;8(2):e55251. doi: 10.1371/journal.pone.0055251. Epub 2013 Feb 14.

11.

Predicting the location of human perirhinal cortex, Brodmann's area 35, from MRI.

Augustinack JC, Huber KE, Stevens AA, Roy M, Frosch MP, van der Kouwe AJ, Wald LL, Van Leemput K, McKee AC, Fischl B; Alzheimer's Disease Neuroimaging Initiative.

Neuroimage. 2013 Jan 1;64:32-42. doi: 10.1016/j.neuroimage.2012.08.071. Epub 2012 Aug 30.

12.

Correlation of CT perfusion and CT volumetry in patients with Alzheimer's disease.

Czarnecka A, Zimny A, Sąsiadek M.

Pol J Radiol. 2010 Apr;75(2):15-21.

13.

Event-related functional magnetic resonance imaging changes during relational retrieval in normal aging and amnestic mild cognitive impairment.

Giovanello KS, De Brigard F, Hennessey Ford J, Kaufer DI, Burke JR, Browndyke JN, Welsh-Bohmer KA.

J Int Neuropsychol Soc. 2012 Sep;18(5):886-97. doi: 10.1017/S1355617712000689. Epub 2012 May 24.

14.

Alliance for aging research AD biomarkers work group: structural MRI.

Jack CR Jr.

Neurobiol Aging. 2011 Dec;32 Suppl 1:S48-57. doi: 10.1016/j.neurobiolaging.2011.09.011. Review.

15.

Mild cognitive impairment: historical development and summary of research.

Golomb J, Kluger A, Ferris SH.

Dialogues Clin Neurosci. 2004 Dec;6(4):351-67.

16.

Multimodal MRI neuroimaging biomarkers for cognitive normal adults, amnestic mild cognitive impairment, and Alzheimer's disease.

Lin AL, Laird AR, Fox PT, Gao JH.

Neurol Res Int. 2012;2012:907409. doi: 10.1155/2012/907409. Epub 2011 Sep 21.

17.

Atrophy in the parahippocampal gyrus as an early biomarker of Alzheimer's disease.

Echávarri C, Aalten P, Uylings HB, Jacobs HI, Visser PJ, Gronenschild EH, Verhey FR, Burgmans S.

Brain Struct Funct. 2011 Jan;215(3-4):265-71. doi: 10.1007/s00429-010-0283-8. Epub 2010 Oct 19.

18.

Entorhinal cortex volume in older adults: reliability and validity considerations for three published measurement protocols.

Price CC, Wood MF, Leonard CM, Towler S, Ward J, Montijo H, Kellison I, Bowers D, Monk T, Newcomer JC, Schmalfuss I.

J Int Neuropsychol Soc. 2010 Sep;16(5):846-55. doi: 10.1017/S135561771000072X.

19.

Hippocampal atrophy patterns in mild cognitive impairment and Alzheimer's disease.

Mueller SG, Schuff N, Yaffe K, Madison C, Miller B, Weiner MW.

Hum Brain Mapp. 2010 Sep;31(9):1339-47. doi: 10.1002/hbm.20934.

20.

Longitudinal MRI atrophy biomarkers: relationship to conversion in the ADNI cohort.

Risacher SL, Shen L, West JD, Kim S, McDonald BC, Beckett LA, Harvey DJ, Jack CR Jr, Weiner MW, Saykin AJ; Alzheimer's Disease Neuroimaging Initiative (ADNI).

Neurobiol Aging. 2010 Aug;31(8):1401-18. doi: 10.1016/j.neurobiolaging.2010.04.029.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk